Search Results for "Seasonale"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Seasonale. Results 1 to 5 of 5 total matches.
See also: levonorgestrel

Seasonale

   
The Medical Letter on Drugs and Therapeutics • Feb 02, 2004  (Issue 1175)
Seasonale ...
Seasonale (Barr), the first "extended-cycle" oral contraceptive, is now available in the US for pregnancy prevention. Active tablets containing 30 ╡g of ethinyl estradiol and 0.15 mg of levonorgestrel are taken for 84 consecutive days, followed by 7 days of inactive tablets, allowing for withdrawal bleeding only four times a year. Other combination oral contraceptives are dispensed as 21 days of active tablets and 7 days of placebo or no tablets, resulting in 13 withdrawal bleeding episodes each year.
Med Lett Drugs Ther. 2004 Feb 2;46(1175):9 |  Show IntroductionHide Introduction

Three New Oral Contraceptives

   
The Medical Letter on Drugs and Therapeutics • Sep 25, 2006  (Issue 1244)
predecessor Seasonale, 2 Seasonique has a 91-day cycle. With both products, active tablets are taken ...
Three new combination oral contraceptives (COCs) with shortened hormone-free intervals, Seasonique, Loestrin 24 Fe and Yaz, have recently been approved by the FDA. All 3 are derivatives of older products.
Med Lett Drugs Ther. 2006 Sep 25;48(1244):77-8 |  Show IntroductionHide Introduction

Quartette: An Ascending-Dose, Extended-Cycle Oral Contraceptive

   
The Medical Letter on Drugs and Therapeutics • Jul 08, 2013  (Issue 1420)
mg (21 days), EE 0.01 mg (7 days) Seasonale (Teva) – LNG 0.15 mg + EE 0.03 mg (84 days), placebo (7 ...
The FDA has approved Quartette (Teva), an extended-cycle combination oral contraceptive containing increasing doses of the estrogen ethinyl estradiol (EE) combined with the progestin levonorgestrel (LNG). The rationale is that a gradual increase in the EE dose may reduce unscheduled bleeding or spotting, a common adverse effect of extended-cycle oral contraceptives.
Med Lett Drugs Ther. 2013 Jul 8;55(1420):54-5 |  Show IntroductionHide Introduction

Lybrel - A Continuous Oral Contraceptive

   
The Medical Letter on Drugs and Therapeutics • Jul 30, 2007  (Issue 1266)
and Seasonale) have a 91-day cycle with only 4 withdrawal bleeds per year. EFFECTIVENESS — Compared ...
Lybrel (Wyeth) is the first FDA-approved low-dose combination oral contraceptive taken 365 days a year without a placebo or pill-free interval. All tablets contain low doses of levonorgestrel (0.09 mg) and ethinyl estradiol (20 mcg). Most oral contraceptives are packaged as a 21/7 cycle (21 days of active tablets and 7 days of placebo), resulting in 13 withdrawal bleeding episodes each year. Two formulations are taken for 24 days followed by 4 days of inert tablets (Yaz and Loestrin 24). Two others (Seasonique and Seasonale) have a 91-day cycle with only 4 withdrawal bleeds per...
Med Lett Drugs Ther. 2007 Jul 30;49(1266):61-2 |  Show IntroductionHide Introduction

Choice of Contraceptives

   
The Medical Letter on Drugs and Therapeutics • May 15, 2023  (Issue 1676)
]) Iclevia (Aurobindo) Jolessa (Teva) Seasonale (Teva) Setlakin (NorthStar Rx) Multiphasic ...
Intrauterine devices (IUDs) and the etonogestrel implant are the most effective reversible contraceptive methods available. Hormonal oral contraceptives, patches, rings, and injectables are also effective in preventing pregnancy. When used alone, barrier and behavioral methods generally have higher failure rates than other methods (see Table 1). Selection of a contraceptive method is usually based on patient-specific factors and personal preference
Med Lett Drugs Ther. 2023 May 15;65(1676):73-80   doi:10.58347/tml.2023.1676a |  Show IntroductionHide Introduction